Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano, +15

PubMed

Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.

Keiji Hirata, N Horikoshi, K Aiba, +9

PubMed

Medicinal ChemistryOncologyHealth SciencesIntact FtChemoprevention Strategy +13

Molecular evolution of acute myeloid leukaemia in relapse: unstable N‐<i>ras</i> and <i>FLT3</i> genes compared with <i>p53</i> gene

Yasuyuki Nakano, Hitoshi Kiyoi, Shuichi Miyawaki, +4

British Journal of Haematology

Prognostic value of <i>p53</i> gene mutations and the product expression in <i>de novo</i> acute myeloid leukemia

Yasuyuki Nakano, Tomoki Naoe, Hitoshi Kiyoi, +14

European Journal Of Haematology

Trough plasma concentration of imatinib reflects BCR–ABL kinase inhibitory activity and clinical response in chronic‐phase chronic myeloid leukemia: A report from the BINGO study

Yuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, +13

Cancer Science

Muscle wasting associated with the long-term use of mTOR inhibitors

Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, +6

Molecular and Clinical Oncology

Effects of .BETA.-Thujaplicin on Anti-Malassezia pachydermatis Remedy for Canine Otitis Externa

Yasuyuki Nakano, Makoto Wada, Hiroyuki Tani, +2

Journal of Veterinary Medical Science

Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study

Ayumu Matsuoka, Osamu Maeda, Takefumi Mizutani, +4

PLoS ONE

Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia

Yasuyuki Nakano, Tomoki Naoe, Hitoshi Kiyoi, +7

Leukemia Research

Hematological MalignancyPoor Clinical SignificanceGeneticsAcute Myeloid LeukemiaHematology +9

Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan

Hiroya Taniguchi, Keisuke Uehara, Goro Nakayama, +18

Translational Oncology